Related Experiment Video

Updated: Jun 19, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

The role of the CXCL10/CXCR3 system in type 1 diabetes

Akira Shimada1, Yoichi Oikawa, Yoshifumi Yamada

  • 1Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. asmd@sc.itc.keio.ac.jp

The Review of Diabetic Studies : RDS
|October 7, 2009
PubMed

Insights

Type 1 diabetes involves immune destruction of pancreatic beta-cells. Understanding the CXCL10/CXCR3 system offers potential new treatments for this autoimmune disease.

Area of Science:

  • Immunology
  • Endocrinology
  • Pathophysiology

Background:

  • Type 1 diabetes is an autoimmune disease causing pancreatic beta-cell destruction, leading to quality of life decline despite insulin therapy.
  • The exact cause of type 1 diabetes is debated, but T-helper cell imbalance, particularly a T-helper 1 (Th1) dominant response, is implicated in beta-cell failure.
  • The glutamic acid decarboxylase (GAD) antigen and GAD-reactive T cells are suggested to play a role in diabetes development by influencing Th cell balance.

Purpose of the Study:

  • To review the role of the CXCL10/CXCR3 system in type 1 diabetes pathogenesis.
  • To explore the involvement of CXCL10 and its receptor CXCR3 in immune responses and beta-cell function.
  • To propose potential therapeutic strategies targeting the CXCL10/CXCR3 pathway for type 1 diabetes treatment.

Main Methods:

  • Literature review of studies investigating the CXCL10/CXCR3 system in type 1 diabetes.
  • Analysis of the involvement of Th1-type chemokines in immune-mediated beta-cell destruction.
  • Examination of the impact of CXCL10/CXCR3 on beta-cell proliferation and survival.

Main Results:

  • The CXCL10/CXCR3 system is implicated in the immune response associated with type 1 diabetes.
  • CXCL10 and CXCR3 contribute to the suppression of pancreatic beta-cell proliferation.
  • A Th1-dominant immune response, involving CXCL10/CXCR3, is crucial in beta-cell failure in type 1 diabetes models.

Conclusions:

  • The CXCL10/CXCR3 system plays a significant role in the pathophysiology of type 1 diabetes.
  • Targeting the CXCL10/CXCR3 pathway presents a promising avenue for developing novel treatments for type 1 diabetes.
  • Further research into the CXCL10/CXCR3 system could lead to effective therapies to halt or reverse disease progression.

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...